UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma

The journal of clinical endocrinology and metabolism, 2013-01, Vol.98 (1), p.181-191

2013

Link zum Volltext

Verfügbarkeit prüfen

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement

Journal of cancer research and clinical oncology, 2022-01, Vol.148 (1), p.205-214

2022

Link zum Volltext

Verfügbarkeit prüfen

Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002852

2023

Link zum Volltext

Verfügbarkeit prüfen

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

International journal of immunopathology and pharmacology, 2020, Vol.34, p.2058738420980258

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple‐Blind, Randomized, Placebo‐Controlled Phase III Clinical Trial (ZoMARS)

Journal of bone and mineral research, 2022-03, Vol.37 (3), p.420-427

2022

Link zum Volltext

Verfügbarkeit prüfen

Vertebral Compression Fractures: Third-Generation Dual-Energy CT for Detection of Bone Marrow Edema at Visual and Quantitative Analyses

Radiology, 2017-07, Vol.284 (1), p.161

2017

Link zum Volltext

Verfügbarkeit prüfen

Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias

Academic radiology, 2022-01, Vol.29 (1), p.e1-e8

2022

Link zum Volltext

Verfügbarkeit prüfen

Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by 18F-FDG and 11C-methionine PET/CT

European journal of radiology, 2022-10, Vol.155, p.110493-110493, Article 110493

2022

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease and imaging‐guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma

British journal of haematology, 2022-08, Vol.198 (3), p.515-522

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy

Physics in medicine & biology, 2018-01, Vol.63 (2), p.025029

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor

Leukemia & lymphoma, 2019-12, Vol.60 (14), p.3573-3576

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.17-18

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry

Experimental and clinical endocrinology & diabetes, 2019-10, Vol.127 (9), p.578

2019

Link zum Volltext

Verfügbarkeit prüfen

Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm 2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias

Academic radiology, 2022-01, Vol.29 (1), p.e1

2022

Link zum Volltext

Verfügbarkeit prüfen

MET-PET and NGS Targeted Sequencing Guides Precision Medicine in a CNS Relapsed MM Patient

Blood, 2017-12, Vol.130, p.5361-5361

2017

Link zum Volltext

Verfügbarkeit prüfen

Case report: subacute tetraplegia in an immunocompromised patient

BMC neurology, 2017-02, Vol.17 (1), p.31-31, Article 31

2017

Link zum Volltext

Verfügbarkeit prüfen

Imaging Techniques for Response Assessment and Follow-Up

Management of Bone Disease and Kidney Failure in Multiple Myeloma, 2021, p.67-90

2021

Link zum Volltext

Verfügbarkeit prüfen

Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide

Hormones & cancer, 2016-06, Vol.7 (3), p.211

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor

Leukemia & lymphoma, 2019, Vol.60 (14), p.3573-3576

2019

Link zum Volltext

Verfügbarkeit prüfen

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

International journal of immunopathology and pharmacology, 2020, Vol.34, p.2058738420980258-2058738420980258

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(10)
Male
(8)
Middle Aged
(7)
Multiple Myeloma
(7)
Adult
(6)
Aged
(6)
Female
(6)
Magnetic Resonance Imaging
(6)
Patients
(5)
Endocrinology & Metabolism
(4)
Retrospective Studies
(4)
Adolescent
(3)
Adrenal Cortex Neoplasms - Mortality
(3)
Adrenocortical Carcinoma - Mortality
(3)
Bone Marrow
(3)
Bone Marrow - Pathology
(3)
Hematology
(3)
Minimal Residual Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement

Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple‐Blind, Randomized, Placebo‐Controlled Phase III Clinical Trial (ZoMARS)

Vertebral Compression Fractures: Third-Generation Dual-Energy CT for Detection of Bone Marrow Edema at Visual and Quantitative Analyses

Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias

Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by 18F-FDG and 11C-methionine PET/CT

Minimal residual disease and imaging‐guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma

Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy

Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor

Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple Myeloma

Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry

Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm 2 Improves the Specificity of Diffusion-Weighted Imaging in Patients with Plasma Cell Dyscrasias

MET-PET and NGS Targeted Sequencing Guides Precision Medicine in a CNS Relapsed MM Patient

Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?

Case report: subacute tetraplegia in an immunocompromised patient

Imaging Techniques for Response Assessment and Follow-Up

Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide

Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma

Suchergebnisse filtern